Intellipharmaceutics: Intellipharmaceutics: Fiscal Q3 Earnings Snapshot

TORONTO (AP) - TORONTO (AP) - Intellipharmaceutics International Inc. (IPCIF) on Monday reported a loss of $1.9 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss of 6 cents. The extended-release drug developer posted revenue of $68,700 in the period. Its adjusted revenue was $69,000. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF